Just for the record—and I think I speak for all of my colleagues—we would love to have more research and development in pharmaceuticals done in Canada. I think that's across all party lines.
I wanted to establish whether you have any concerns that these regulatory changes will negatively impact that, and I got my answer.
Similarly, do you think that the PMPRB regulatory changes proposed for January 1 will result in fewer clinical trials in Canada?